Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate

Classification criteria for psoriatic arthritis: Development of new criteria from a large international study

William J. Taylor, Dafna D. Gladman, Philip Helliwell et al. · Arthritis & Rheumatism · 2006 · 3.7K citations

Medicine, Biostatistics, Clinical Sciences +16

Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment

Laura C. Coates, Jaap Fransen, Philip Helliwell · Annals of the Rheumatic Diseases · 2009 · 672 citations

Medicine, Clinical Sciences, Internal Medicine +17

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis

Alan Menter, Kenneth B. Gordon, Craig L. Leonardi et al. · Journal of the American Academy of Dermatology · 2010 · 159 citations

Life Sciences, Dermatology, Immunology +9

Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients

Luisa Costa, Francesco Caso, Mariangela Atteno et al. · Clinical Rheumatology · 2013 · 116 citations

Medicine, Pharmacology, Pharmacotherapy +15

Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study

Luisa Costa, Francesco Caso, Lanfranco D’Elia et al. · Clinical Rheumatology · 2011 · 115 citations

Medicine, Clinical Sciences, Internal Medicine +13